

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 6 | 5 | 1 | 1 | 14 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | — | 1 | 1 | — | 2 |
| Hepatitis c | D006526 | — | B19.2 | — | — | — | 1 | — | 1 |
| Hepatitis | D006505 | — | K75.9 | — | — | — | 1 | — | 1 |
| Hepatitis a | D006506 | EFO_0007305 | B15 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | — | — | 4 | 2 | 4 | — | — | 9 |
| Colorectal neoplasms | D015179 | — | — | 4 | 4 | 3 | — | — | 9 |
| Lung neoplasms | D008175 | — | C34.90 | 2 | 1 | 2 | — | — | 5 |
| Neoplasms | D009369 | — | C80 | 4 | — | 1 | — | — | 5 |
| Rectal neoplasms | D012004 | — | — | 2 | 1 | 2 | — | — | 5 |
| Pancreatic ductal carcinoma | D021441 | — | — | 2 | 1 | 1 | — | — | 4 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 1 | 2 | 2 | — | — | 4 |
| Colonic neoplasms | D003110 | — | C18 | 2 | — | 2 | — | — | 4 |
| Lymphoma | D008223 | — | C85.9 | — | 1 | 2 | — | — | 3 |
| Hiv-1 | D015497 | — | — | — | 1 | 2 | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | 5 | — | — | — | 5 |
| Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | — | 1 |
| Glioblastoma | D005909 | EFO_0000515 | — | 1 | 1 | — | — | — | 1 |
| Cholangiocarcinoma | D018281 | — | C22.1 | 1 | 1 | — | — | — | 1 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | — | 1 | — | — | — | 1 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | 1 | — | — | — | 1 |
| Adenocarcinoma | D000230 | — | — | — | 1 | — | — | — | 1 |
| Triple negative breast neoplasms | D064726 | — | — | — | 1 | — | — | — | 1 |
| Urinary bladder neoplasms | D001749 | — | C67 | — | 1 | — | — | — | 1 |
| Urinary bladder diseases | D001745 | — | N32.9 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 2 | — | — | — | — | 2 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | — | — | — | — | 1 |
| Drug common name | Doxecitine |
| INN | doxecitine |
| Description | Deoxycytidine is a deoxyribonucleoside, a component of deoxyribonucleic acid. It is similar to the ribonucleoside cytidine, but with one hydroxyl group removed from the C2' position.
|
| Classification | Small molecule |
| Drug class | H2-receptor antagonists (cimetidine type) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1 |
| PDB | — |
| CAS-ID | 951-77-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL66115 |
| ChEBI ID | 15698 |
| PubChem CID | 637 |
| DrugBank | DB02594 |
| UNII ID | 0W860991D6 (ChemIDplus, GSRS) |
